Investigation of REFINED CNN ensemble learning for anti-cancer drug sensitivity prediction

被引:13
|
作者
Bazgir, Omid [1 ]
Ghosh, Souparno [2 ]
Pal, Ranadip [1 ]
机构
[1] Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA
[2] Univ Nebraska Lincoln, Dept Math & Stat, Lincoln, NE 68583 USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
DIMENSIONALITY REDUCTION;
D O I
10.1093/bioinformatics/btab336
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Motivation: Anti-cancer drug sensitivity prediction using deep learning models for individual cell line is a significant challenge in personalized medicine. Recently developed REFINED (REpresentation of Features as Images with NEighborhood Dependencies) CNN (Convolutional Neural Network)-based models have shown promising results in improving drug sensitivity prediction. The primary idea behind REFINED-CNN is representing high dimensional vectors as compact images with spatial correlations that can benefit from CNN architectures. However, the mapping from a high dimensional vector to a compact 2D image depends on the a priori choice of the distance metric and projection scheme with limited empirical procedures guiding these choices. Results: In this article, we consider an ensemble of REFINED-CNN built under different choices of distance metrics and/or projection schemes that can improve upon a single projection based REFINED-CNN model. Results, illustrated using NCI60 and NCI-ALMANAC databases, demonstrate that the ensemble approaches can provide significant improvement in prediction performance as compared to individual models. We also develop the theoretical framework for combining different distance metrics to arrive at a single 2D mapping. Results demonstrated that distance-averaged REFINED-CNN produced comparable performance as obtained from stacking REFINED-CNN ensemble but with significantly lower computational cost.
引用
收藏
页码:I42 / I50
页数:9
相关论文
共 50 条
  • [1] Anti-cancer Drug Activity Prediction by Ensemble Learning
    Tolan, Ertan
    Tan, Mehmet
    KDIR: PROCEEDINGS OF THE 8TH INTERNATIONAL JOINT CONFERENCE ON KNOWLEDGE DISCOVERY, KNOWLEDGE ENGINEERING AND KNOWLEDGE MANAGEMENT - VOL. 1, 2016, : 431 - 436
  • [2] Ensemble transfer learning for the prediction of anti-cancer drug response
    Zhu, Yitan
    Brettin, Thomas
    Evrard, Yvonne A.
    Partin, Alexander
    Xia, Fangfang
    Shukla, Maulik
    Yoo, Hyunseung
    Doroshow, James H.
    Stevens, Rick L.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [3] Ensemble transfer learning for the prediction of anti-cancer drug response
    Yitan Zhu
    Thomas Brettin
    Yvonne A. Evrard
    Alexander Partin
    Fangfang Xia
    Maulik Shukla
    Hyunseung Yoo
    James H. Doroshow
    Rick L. Stevens
    Scientific Reports, 10
  • [4] A computational model for anti-cancer drug sensitivity prediction
    Zhao, Zheming
    Li, Kezhi
    Toumazou, Chris
    Kalofonou, Melpomeni
    2019 IEEE BIOMEDICAL CIRCUITS AND SYSTEMS CONFERENCE (BIOCAS 2019), 2019,
  • [5] Reliable anti-cancer drug sensitivity prediction and prioritization
    Lenhof, Kerstin
    Eckhart, Lea
    Rolli, Lisa-Marie
    Volkamer, Andrea
    Lenhof, Hans-Peter
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [6] An Integrated Approach to Anti-Cancer Drug Sensitivity Prediction
    Berlow, Noah
    Haider, Saad
    Wan, Qian
    Geltzeiler, Mathew
    Davis, Lara E.
    Keller, Charles
    Pal, Ranadip
    IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2014, 11 (06) : 995 - 1008
  • [7] Robust Prediction of Anti-Cancer Drug Sensitivity and Sensitivity-Specific Biomarker
    Park, Heewon
    Shimamura, Teppei
    Miyano, Satoru
    Imoto, Seiya
    PLOS ONE, 2014, 9 (10):
  • [8] Anti-cancer drug sensitivity in sinonasal squamous cancer
    Garcia-Inclan, Cristina
    Lopez, Fernando
    Potes-Ares, Sira
    Llorente, Jose L.
    Hermsen, Mario
    CELLULAR ONCOLOGY, 2012, 35 : S46 - S46
  • [9] Prediction of anti-cancer drug response by kernelized multi-task learning
    Tan, Mehmet
    ARTIFICIAL INTELLIGENCE IN MEDICINE, 2016, 73 : 70 - 77
  • [10] Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation
    Zhou, Jing -Bo
    Tang, Dongyang
    He, Lin
    Lin, Shiqi
    Lei, Josh Haipeng
    Sun, Heng
    Xu, Xiaoling
    Deng, Chu-Xia
    PHARMACOLOGICAL RESEARCH, 2023, 194